Phospholipid Drug Conjugate MoA Animation
SCIENTIFIC ANIMATION | Investor, HCP & patient education
Cellectar’s Phospholipid Drug Conjugate Candidate platform provides selective delivery of a diverse range of oncologic warheads to cancerous cells of varied origin.
We developed this Mechanism of Action (MoA) animation that Cellectar utilized to drive traffic to their website, for investor relations, and their clinical trial sites. In May 2019 the company website attracted 13,000 visitors, with over a third visiting the MoA page. The animation has also been a useful asset for their social media activities, featuring in the most liked and shared posts to date.
“Extremely happy everybody was great on the team. They answered all our questions and made it look easy. The end result is perfect.”
Executive Coordinator, Cellectar Biosciences
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.